COVID-19 vaccine equity: a health systems and policy perspective. (2nd January 2022)

• Record Type: Journal Article
• Authors: Van De Pas, Remco; Widdowson, Marc-Alain; Ravinetto, Raffaella; N Srinivas, Prashanth; Ochoa, Theresa J.; Fofana, Thierno Oumar; Van Damme, Wim
• Is Part Of: Expert review of vaccines. Volume 21:Number 1(2022)
• Page Start: 25
• Page End: 36
• Publication Date: 2022-01-02
• Subjects: ACT-A -- capacity development -- COVID-19 pandemic -- vaccine equity -- low-income countries -- research & development ecosystem -- Tanahashi health systems framework -- technology transfer -- TRIPS; Vaccines -- Periodicals; Vaccination -- Periodicals; 615.37205
• DOI: 10.1080/14760584.2022.2004125
• Languages: English
• ISSNs: 1476-0584

Abstract

ABSTRACT: Introduction: The global COVID-19 vaccine rollout has highlighted inequities in the accessibility of countries to COVID-19 vaccines. Populations in low- and middle-income countries have found it difficult to have access to COVID-19 vaccines. Areas covered: This perspective provides analyses on historical and contemporary policy trends of vaccine development and immunization programs, including the current COVID-19 vaccination drive, and governance challenges. Moreover, we also provide a comparative health system analysis of the COVID-19 vaccine deployment in some countries from different continents. It recommends that the international Access to COVID-19 Tools Accelerator (ACT-A) partnership requires a strong governance mechanism and urgent financial investment. Expert opinion: All WHO member states should agree on technology transfer and voluntary license-sharing via a commonly governed technology access pool and supported by a just Intellectual Property regime. Contextualized, dynamic understandings and country-specific versions of health systems strengthening are needed to improve vaccine equity in a sustainable matter.